RE:RE:New presentation on the website if interestedoh dear oh dear...
Cash 40M, but that was as of Sep 30... Does that mean ONCY doesn't know how much of that they have left, or it took 3 months to create the new slide pack and they forgot this..?? More diltuion, and I'm betting Matt will tell us that another reverse split will ensure they can go it alone... LOL... they've been going it alone for 25 years... and no-one else wants to play.
NO slide on partnerships... Perhaps they just don't want to admit that the so called partnership with Adlai Nortye is no more... ONCY used to claim that this partnership validated their product... Funny how Adlai Nortye ran the necessary bridging studies, was all ready for a pH III in China and now... nothing, they don't even list Pela in their pipeline .
mBC - they are awaiting the final OS data, expected this year... that's stating clearly that survival is prolonged, but Pela is not a cure (but we knew this anyway)... But the early excitement about a CR from the Panc trial had all the pumpers quite giddy for a while - no longer mentioned... I wonder what happened to that patient?
So, now Anal cancer is back on the menu... excellent... just need to run some run in safety studies over the next decade, on a handful of patients, and we should know that it's safe to proceed to phase Ib. Faster than fast track... magic
Good lord sweet Jesus... Matt... please just get out of your own way, and sell up.